Biomea Fusion Inc. (BMEA)
Biomea Fusion Statistics
Share Statistics
Biomea Fusion has 37.57M shares outstanding. The number of shares has increased by 0.82% in one year.
| Shares Outstanding | 37.57M |
| Shares Change (YoY) | 0.82% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 63.29% |
| Shares Floating | 32.8M |
| Failed to Deliver (FTD) Shares | 15.49K |
| FTD / Avg. Volume | 2.04% |
Short Selling Information
The latest short interest is 10.47M, so 28.88% of the outstanding shares have been sold short.
| Short Interest | 10.47M |
| Short % of Shares Out | 28.88% |
| Short % of Float | 47.03% |
| Short Ratio (days to cover) | 15.62 |
Valuation Ratios
The PE ratio is -1.01 and the forward PE ratio is -0.69. Biomea Fusion's PEG ratio is -0.09.
| PE Ratio | -1.01 |
| Forward PE | -0.69 |
| PS Ratio | 0 |
| Forward PS | 0.2 |
| PB Ratio | 2.72 |
| P/FCF Ratio | -1.16 |
| PEG Ratio | -0.09 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Biomea Fusion.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.15, with a Debt / Equity ratio of 0.17.
| Current Ratio | 3.15 |
| Quick Ratio | 3.15 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | -0.06 |
| Debt / FCF | -0.07 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-1.31M |
| Employee Count | 106 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -80.87% in the last 52 weeks. The beta is -0.09, so Biomea Fusion's price volatility has been lower than the market average.
| Beta | -0.09 |
| 52-Week Price Change | -80.87% |
| 50-Day Moving Average | 2.55 |
| 200-Day Moving Average | 5.71 |
| Relative Strength Index (RSI) | 48.03 |
| Average Volume (20 Days) | 759.22K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -144.07M |
| Net Income | -138.43M |
| EBITDA | -144.07M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -3.83 |
Balance Sheet
The company has 58.28M in cash and 8.77M in debt, giving a net cash position of 49.51M.
| Cash & Cash Equivalents | 58.28M |
| Total Debt | 8.77M |
| Net Cash | 49.51M |
| Retained Earnings | -387.25M |
| Total Assets | 79.94M |
| Working Capital | 46.66M |
Cash Flow
In the last 12 months, operating cash flow was -119.89M and capital expenditures -362K, giving a free cash flow of -120.26M.
| Operating Cash Flow | -119.89M |
| Capital Expenditures | -362K |
| Free Cash Flow | -120.26M |
| FCF Per Share | -3.33 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BMEA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for BMEA is $22, which is 968% higher than the current price. The consensus rating is "Buy".
| Price Target | $22 |
| Price Target Difference | 968% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
Scores
| Altman Z-Score | -10.66 |
| Piotroski F-Score | 1 |